SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ankur Drugs and Pharma informs about Board Meeting

18 May 2013 Evaluate

Ankur Drugs and Pharma has informed that a meeting of the Board of Directors of the Company will be held on May 25, 2013: To approve the un-audited financial results of the Company for the Quarter Ended March 31, 2013 and to approve the resignation of  Anil Kumar Khadke as Nominee Director of Central Bank of India w.e.f. March 15, 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1782.00
Dr. Reddys Lab 1272.75
Cipla 1388.75
Zydus Lifesciences 1109.05
Lupin 2270.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×